-
FDA Clears Pardes IND Application for COVID Antiviral Candidate
contractpharma
February 04, 2022
PB-0451 is currently being evaluated in a Phase 1 placebo-controlled study in healthy volunteers evaluating safety, tolerability, and pharmacokinetics.
-
COVID Cases Surge Once Again Amidst a Lack of Diagnostic Supplies
prnewswire
January 29, 2022
The pandemic remains a major concern around the world. According to recent data published by Johns Hopkins University's Center for Systems Science and Engineering, more than 5.6 million people have died from the disease worldwide...
-
iBio Advances Lead COVID Vax Program IBIO-202
contractpharma
January 27, 2022
Moving forward with IND-enabling challenge studies for its second-generation vaccine candidate targeting the nucleocapsid (“N”) protein.
-
FDA Halts Use of Regeneron, Lilly COVID Antibody Therapies
contractpharma
January 25, 2022
Cites the therapies are less able to target Omicron because of its mutations.
-
Pandemic Especially Tough on Kids With ADHD
drugs.com
January 25, 2022
Living through the pandemic has not been easy for kids, but it has really thrown off children who have attention...
-
Free N95 Masks Begin Arriving in U.S. Pharmacies
drugs.com
January 25, 2022
The distribution of free N95 masks for Americans has begun, the Biden administration said Monday.
-
Three doses of mRNA COVID vaccines very effective against Omicron and Delta: Study
ExpressPharma
January 24, 2022
The study, from the US Centers for Disease Control and Prevention (CDC), found that boosters of mRNA COVID vaccines are 82 per cent effective in protecting against Omicron variant-associated ED visits.
-
FDA Limits Use of Two COVID Antibody Treatments
drugs.com
January 24, 2022
The U.S. Food and Drug Administration is curtailing the use of two monoclonal antibody treatments that do not appear to work...
-
Can CBD Help Curb COVID? Maybe, But More Study Needed
drugs.com
January 24, 2022
Cannabidiol, a compound derived from marijuana, appears to show promise in blocking replication...
-
COVID Can Affect Brains of Hospitalized Kids
drugs.com
January 24, 2022
The coronavirus can leave more than 40% of children hospitalized for COVID-19 with headaches and other lingering neurological symptoms, a new study claims.